S. H. Oguz Et Al. , "Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review," IMMUNOTHERAPY , vol.13, no.14, pp.1157-1164, 2021
Oguz, S. H. Et Al. 2021. Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review. IMMUNOTHERAPY , vol.13, no.14 , 1157-1164.
Oguz, S. H., ÜNLÜTÜRK, U., AKSOY, S., & Erbas, T., (2021). Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review. IMMUNOTHERAPY , vol.13, no.14, 1157-1164.
Oguz, SEDA Et Al. "Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review," IMMUNOTHERAPY , vol.13, no.14, 1157-1164, 2021
Oguz, SEDA H. Et Al. "Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review." IMMUNOTHERAPY , vol.13, no.14, pp.1157-1164, 2021
Oguz, S. H. Et Al. (2021) . "Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review." IMMUNOTHERAPY , vol.13, no.14, pp.1157-1164.
@article{article, author={SEDA HANİFE OĞUZ BAYKAL Et Al. }, title={Clinical course and management of pembrolizumab-associated isolated adrenocorticotrophic hormone deficiency: a new case and literature review}, journal={IMMUNOTHERAPY}, year=2021, pages={1157-1164} }